Ingredient or product comparison
GHK-Cu for Osteoarthritis: Formulation Comparison
Topical (cream/serum) Low. Stratum corneum barrier limits peptide penetration; unlikely to reach intra-articular cartilage at therapeutic concentrations Twice daily application High. Self-administered, no special equipment required Best suited for periarticula
This source-based comparison does not add ratings or recommend a winner.
- Topical (cream/serum)
- Low. Stratum corneum barrier limits peptide penetration; unlikely to reach intra-articular cartilage at therapeutic concentrations
- Twice daily application
- High. Self-administered, no special equipment required
- Best suited for periarticular soft tissue inflammation, not deep cartilage repair. Expect modest symptomatic relief, not structural change.
- Subcutaneous injection
- Moderate. Systemic circulation achieved but diluted before reaching target joint; requires frequent dosing due to 30-min half-life
- Daily or every other day
- Moderate. Requires injection training, sterile technique, refrigerated storage
- Practical for research protocols evaluating systemic effects; less efficient for isolated joint treatment compared to local delivery.
- Intra-articular injection
- High. Direct delivery to synovial space maximizes local concentration and cartilage exposure
- Weekly or biweekly (rapid synovial turnover requires repeated administration)
- Low. Requires clinical setting, sterile technique, ideally ultrasound guidance; self-administration not feasible
- Most likely to replicate preclinical study outcomes; logistical and cost barriers limit accessibility. Consider combining with viscosupplementation for prolonged residence time.